These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 12874437)

  • 61. Regulation of lens aldose reductase activity by nitric oxide.
    Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
    Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
    [TBL] [Abstract][Full Text] [Related]  

  • 62. More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice.
    Yeung CM; Lo AC; Cheung AK; Chung SS; Wong D; Chung SK
    J Neurosci Res; 2010 Jul; 88(9):2026-34. PubMed ID: 20143423
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
    Chang KC; Li L; Sanborn TM; Shieh B; Lenhart P; Ammar D; LaBarbera DV; Petrash JM
    J Nat Prod; 2016 May; 79(5):1439-44. PubMed ID: 27140653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway.
    Lu Q; Hao M; Wu W; Zhang N; Isaac AT; Yin J; Zhu X; Du L; Yin X
    Acta Biochim Pol; 2018; 65(1):35-41. PubMed ID: 29281744
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aldose reductase and sorbitol dehydrogenase distribution in rat kidney.
    Corder CN; Collins JG; Brannan TS; Sharma J
    J Histochem Cytochem; 1977 Jan; 25(1):1-8. PubMed ID: 401844
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evidence for existence of polyol pathway in cultured rat mesangial cells.
    Kikkawa R; Umemura K; Haneda M; Arimura T; Ebata K; Shigeta Y
    Diabetes; 1987 Feb; 36(2):240-3. PubMed ID: 3100369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P; Krishnaswamy K; Reddy GB
    Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in an in vitro diabetic retinopathy model.
    Sarikaya M; Yazihan N; Daş Evcimen N
    Can J Physiol Pharmacol; 2020 Apr; 98(4):243-251. PubMed ID: 31743046
    [TBL] [Abstract][Full Text] [Related]  

  • 69. NADPH-dependent reduction of glyceraldehyde: a unusually high activity in the lens of the camel (Camelus dromedarius).
    Del Corso A; Osman AM; Mohamed AS; Camici M; Barsacchi D; Tozzi MG; Mura U
    Boll Soc Ital Biol Sper; 1989 Mar; 65(3):235-42. PubMed ID: 2504255
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
    ElGamal H; Munusamy S
    Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Colocalization of polyol-metabolizing enzymes and immunological detection of fructated proteins in the female reproductive system of the rat.
    Kaneko T; Iuchi Y; Takahashi M; Fujii J
    Histochem Cell Biol; 2003 Apr; 119(4):309-15. PubMed ID: 12684816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
    Kanth VR; Lavanya K; Srinivas J; Raju TN
    Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aldose reductase, still a compelling target for diabetic neuropathy.
    Oates PJ
    Curr Drug Targets; 2008 Jan; 9(1):14-36. PubMed ID: 18220710
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes.
    Chang KC; Paek KS; Kim HJ; Lee YS; Yabe-Nishimura C; Seo HG
    Mol Pharmacol; 2002 May; 61(5):1184-91. PubMed ID: 11961137
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activities of NADPH-dependent reductases and sorbitol dehydrogenase in canine and feline lenses.
    Salgado D; Forrer RS; Spiess BM
    Am J Vet Res; 2000 Oct; 61(10):1322-4. PubMed ID: 11039569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Osmoregulation of aldose reductase and sorbitol dehydrogenase in cultivated interstitial cells of rat renal inner medulla.
    Steffgen J; Kampfer K; Grupp C; Langenberg C; Müller GA; Grunewald RW
    Nephrol Dial Transplant; 2003 Nov; 18(11):2255-61. PubMed ID: 14551351
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic analysis of aldose reductase in diabetic complications.
    Chung SS; Chung SK
    Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Localization of the polyol pathway in the human kidney.
    Zopf S; Flämig J; Schmid H; Miosge N; Blaschke S; Hahn EG; Müller GA; Grunewald RW
    Histol Histopathol; 2009 Apr; 24(4):447-55. PubMed ID: 19224447
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Establishment of mouse as an animal model for study of diabetic cataracts: biochemical studies.
    Hegde KR; Henein MG; Varma SD
    Diabetes Obes Metab; 2003 Mar; 5(2):113-9. PubMed ID: 12630936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.